Lenovo's Legend Capital and venture capital firm DCM reinvested in a consortium alongside GL Capital Group in Pharmaron's $40m C round.
Pharmaron, a China-based service company for drug developers backed by computer group Lenovo’s corporate venturing unit, has raised $40m in its series C round.
Lenovo’s Legend Capital and venture capital firm DCM reinvested in a consortium alongside GL Capital Group.
Jeffrey Li, founding partner of GL and former chief executive of drugs maker Novartis’ China subsidiary, said: "Our strategic investment will boost Pharmaron’s service capability and capacity to serve the pharmaceutical and biotech industry better."
Last month, Pharmaron…
